GLP-1 pills are coming, and they could revolutionize weight-loss ...
WEBSep 17, 2024 — At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing.
Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
WEBJun 26, 2023 — Eli Lilly’s Mounjaro, cleared for type 2 diabetes and awaiting FDA approval for weight loss, targets both GLP-1 and a hormone called GIP, and has produced weight loss of 21 to 23%.
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
WEBOn Thursday, ahead of the diabetes conference, Denmark-based biotech firm Zealand Pharma released data that showed a high dose of its experimental weight loss drug petrelintide helped reduce body...
Considering GLP-1 medications? What they are and why lifestyle …
WEBThe good news is a class of medications called GLP-1 (glucagon-like peptide 1) agonists are emerging as true game changers, helping to control appetite and hunger, and allowing some people to shed pounds they’ve struggled to lose for years.
FDA approves Eli Lilly’s Zepbound, a weight loss drug ... - NBC News
WEBNov 8, 2023 — The FDA has approved Zepbound, an injectable weight loss drug from Eli Lilly that helped people lose up to 52 lbs in 16 months during clinical trials.
Science’s 2023 Breakthrough of the Year: Weight loss drugs
WEBDec 14, 2023 — The trials were the first to show in large numbers that GLP-1 drugs produced meaningful health benefits beyond weight loss itself. Meanwhile, a trial examining whether semaglutide delays kidney disease progression in diabetes patients showed such positive outcomes it was stopped early.
New GLP-1 weight loss drug Zepbound approved by FDA: What …
WEBNov 14, 2023 — The FDA recently approved a new Eli Lilly drug, Zepbound (tirzepatide), for chronic weight management in adults with at least one weight-related health condition.
After GLP-1, what’s next for weight loss? - Nature
WEBJun 6, 2023 — The GLP-1 agonist Wegovy has re-energized the hunt for obesity treatments. Alternatives — ranging from bitter taste compounds to lean muscle boosters and bacteria — are already in the clinic.
More fiber in the diet may help boost levels of GLP-1, an Ozempic ... - NPR
WEBOct 30, 2023 — Popular weight-loss drugs mimic GLP-1, a hormone the body makes naturally after eating. Turns out some foods trigger GLP-1 better than others, making us feel full and eat less.
Where Ozempic, Wegovy and New Weight Loss Drugs Came …
WEBAug 17, 2023 — After tedious trial and error, Novo Nordisk produced liraglutide, a GLP-1 drug that lasted long enough for daily injections.